- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 5 residues within 4Å:- Chain C: N.141, N.153, S.155, H.170, D.318
Ligand excluded by PLIPNAG.6: 4 residues within 4Å:- Chain C: N.232, T.234, S.272, H.349
Ligand excluded by PLIPNAG.7: 6 residues within 4Å:- Chain C: Q.291, N.293, N.329, V.330, S.331, R.440
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain C: N.299, I.320, V.438
Ligand excluded by PLIPNAG.9: 4 residues within 4Å:- Chain C: N.293, T.295, H.327, N.329
Ligand excluded by PLIPNAG.10: 4 residues within 4Å:- Chain C: N.360, T.369, D.383, S.385
Ligand excluded by PLIPNAG.11: 5 residues within 4Å:- Chain C: P.289, Q.291, V.442, N.444
- Ligands: NAG-NAG-BMA-MAN.1
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain C: S.385, G.386, N.389
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain D: N.100, S.102
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain D: N.107, S.109, E.110
- Chain E: S.107
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain D: K.122, E.123, N.126
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain G: N.153, H.170, L.172, D.318
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain G: N.232, T.234, S.272, H.349
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain G: Q.291, N.293, N.329, S.331, R.440
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain G: N.299, I.320, G.437, V.438
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain G: N.293, T.295, H.327, N.329, S.409
Ligand excluded by PLIPNAG.21: 5 residues within 4Å:- Chain G: N.360, S.361, T.369, D.383, S.385
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain G: N.260, L.263, P.289, N.444
- Ligands: NAG-NAG-BMA-MAN.3
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain G: E.92, N.93
- Chain H: G.16, S.17
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain G: S.385, G.386, N.389
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain H: N.100, S.102
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain H: N.107, S.109, E.110
- Chain I: S.107
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain K: N.141, N.153, H.170, D.318
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain K: W.101, N.232, T.234, S.272
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain K: Q.291, N.293, S.331, R.440
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain K: N.299, I.320, G.437, V.438
Ligand excluded by PLIPNAG.31: 6 residues within 4Å:- Chain K: N.293, T.295, H.327, N.329, S.409, R.440
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain K: N.360, S.361, T.369, D.383, S.385
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain K: N.260, P.289, V.442, N.444
- Ligands: NAG-NAG-BMA-MAN.4
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain K: E.92, N.93
- Chain L: G.13, S.17
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain K: S.385, G.386, N.389
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain L: N.107, S.109
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain L: K.122, E.123, S.125, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Caniels, T.G. et al., Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site. Sci Immunol (2024)
- Release Date
- 2024-05-29
- Peptides
- 21M20 heavy chain variable region: A
21M20 light chain variable region: B
BG505 GT1.1 SOSIP gp120: CGK
Envelope glycoprotein gp41: DHL
RM20A3 heavy chain variable region: EIM
RM20A3 light chain variable region: FJN
21N13 heavy chain variable region: OQS
21N13 light chain variable region: PRT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AG
CK
DD
BH
GL
IE
EI
JM
KF
FJ
MN
NO
OQ
QS
SP
PR
RT
T
SMTL ID : 8sw4.1
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
21M20 heavy chain variable region
21M20 light chain variable region
BG505 GT1.1 SOSIP gp120
Envelope glycoprotein gp41
RM20A3 heavy chain variable region
Toggle Identical (IM)RM20A3 light chain variable region
Toggle Identical (FJN)21N13 heavy chain variable region
21N13 light chain variable region
Toggle Identical (RT)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 | 6mu8.1 more...less...6nf2.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mdu.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8tjr.1 | 8tjs.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1